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Pygo2 opens chromatin and cycles cells
B
y spreading an active 
chromatin state, Pygo2 
prompts the prolifera-
tion of mammary gland progeni-
tor cells, report Gu et al.
The fl  y version of Pygo2, 
Pygopus, is essential for Wg 
signaling. But the relationship 
between mammalian Wg (Wnt) 
and Pygo2 is less clear. Pygo2 is necessary for the development of 
a number of tissues, but in the two best studied—eye and testis—it 
has no need for Wnt.
Gu et al. looked at the relationship between Wnt and Pygo2 
in mammary gland epithelial cells, where both proteins have been 
linked with cancer.
Pygo2 was expressed in mammary progenitor cells in the embryo 
and adult mouse, where it seemed to specifi  cally regulate proliferation. 
Mammary epithelial cells that lacked Pygo2 still generated mature cell 
types, despite progenitor cell numbers being reduced.
Is Pygo2’s proliferative power driven by Wnt? It seems so. The 
team found that in mice that lacked Pygo2 in mammary epithelial 
cells, -catenin (the cellular effector of Wnt) could no longer induce 
aberrant proliferation. Wnt target genes were also down-regulated 
and this correlated with a reduction of histone H3 lysine 4 (H3K4) 
trimethylation—an epigenetic modifi  cation associated with active 
chromatin. Pygo2 recruited H3K4 methyltransferases, showed the 
team, and also bound to di- and trimethylated H3K4 suggesting it 
works in a positive feedback loop to spread the active chromatin 
mark. This activity was necessary for Pygo2-driven proliferation.
Pygo2’s chromatin activity wasn’t limited to Wnt targets, 
however. Pygo2 also associated with histone methyltransferase in 
bulk chromatin. This suggests Pygo2 is regulated by other pathways, 
and might explain its Wnt independence in certain tissues.
Gu, B., et al. 2009. J. Cell Biol. doi:10.1083/jcb.200810133.
Heart saves muscle
A 
heart muscle protein can 
replace its missing skel-
etal muscle counterpart 
to give mice with myopathy a long 
and active life, show Nowak et al.
The contraction machinery 
protein, actin, exists in differ-
ent forms in the adult heart and 
skeletal muscles. The heart form, 
ACTC, is also the dominant form 
in skeletal muscle of the fetus. But 
during development, the skeletal form, ACTA1, increases in production 
and by birth has taken over. It is not clear why the switch occurs, or why 
it doesn’t occur in the heart, but it happens in every higher vertebrate 
and, for that reason, has been considered vitally important.
Mutations to the ACTA1 gene cause a rare but serious myopathy. 
Most patients die within the fi  rst year of life and some are born almost 
completely paralyzed. Mice lacking ACTA1 die nine days after birth.
Nowak et al. wondered if ACTC could compensate for a 
lack of ACTA1. The two proteins differ only slightly but, like the 
developmental switch in production, this difference is conserved 
across species. Many researchers therefore assumed such 
compensation would never work.
But it did. Nowak and colleagues crossed Acta1 mutant 
mice with transgenic mice that express human ACTC at high 
levels in skeletal muscle cells. The resulting mice didn’t die at 
nine days. In fact, almost all of them (93.5%) survived more 
than three months, and some more than two years. The mice’s 
locomotor performance was comparable with wild-type, as was 
their overall muscle strength (though individual muscle fi  bers 
were slightly weaker), and their endurance was actually higher—
they ran faster and for longer.
This begs the question, Why do we even have ACTA1? Besides 
pondering that, Nowak and colleagues are also working out how to boost 
endogenous ACTC as a possible therapy for ACTA1-lacking patients.
Nowak, K.J., et al. 2009. J. Cell Biol. doi:10.1083/jcb.200812132.
Muscle cell architecture looks 
normal in transgenic mice that lack 
ACTA1 but express human ACTC.
Dynamics of staying put
W
ithout cell–cell con-
nections our bodies 
would fall apart.
McGill et al. have now delved 
into the dynamics of connec-
tion construction.
The connections are called 
adherens junctions. Within each 
cell these junctions are built, not 
by assembling proteins at single 
sites, but by bringing two different protein complexes together, the 
team now shows. One of the complexes, Bazooka clusters, remains 
steadfast at the cell cortex and catches the other complex, the 
cadherin–catenin clusters, as they fl  ow along in the membrane.
To determine these dynamics, the team followed fl  uorescently 
tagged versions of the complexes in fl  y embryos at a stage called 
cellularization—when one giant multinucleated cell becomes an 
epithelial layer of mononucleated cells.
Bazooka clusters formed at the contacts between these 
cells. Meanwhile, cadherin–catenin clusters fi  rst formed between 
microvilli structures on the apical surface. They then moved down 
to the cell–cell contacts, where the Bazooka clusters were waiting.
In between microvilli might seem like a strange place to form 
complexes involved in cell–cell contact, but senior author Tony Harris 
suggests that the movement of the microvilli membranes might help 
accumulate the cadherin and catenin into clusters. Also, at the transition 
region between apical and lateral (cell–cell contact) membranes, 
microvilli can interlock. This could then produce clusters between 
neighboring cells enabling the cells to grab hold of each other.
McGill, M.A., et al. 2009. J. Cell Biol. doi:10.1083/jcb.200812146.
Without Pygo2 (right) mammary 
glands have fewer cycling 
progenitor cells (brown).
Cadherin clusters (green) form 
between microvilli (inset) before 
teaming up with Bazooka 
clusters at lateral membranes.